Gilead Sciences Inc (GILD)
66.96
+0.20
(+0.30%)
USD |
NASDAQ |
Apr 22, 16:00
66.99
+0.03
(+0.04%)
After-Hours: 20:00
Gilead Sciences Market Cap: 83.42B for April 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 83.42B |
| April 19, 2024 | 83.17B |
| April 18, 2024 | 82.42B |
| April 17, 2024 | 83.38B |
| April 16, 2024 | 83.85B |
| April 15, 2024 | 84.40B |
| April 12, 2024 | 84.80B |
| April 11, 2024 | 85.52B |
| April 10, 2024 | 84.86B |
| April 09, 2024 | 87.13B |
| April 08, 2024 | 86.48B |
| April 05, 2024 | 86.68B |
| April 04, 2024 | 86.64B |
| April 03, 2024 | 88.31B |
| April 02, 2024 | 89.81B |
| April 01, 2024 | 90.79B |
| March 28, 2024 | 91.25B |
| March 27, 2024 | 90.95B |
| March 26, 2024 | 90.21B |
| March 25, 2024 | 90.42B |
| March 22, 2024 | 90.46B |
| March 21, 2024 | 91.05B |
| March 20, 2024 | 92.16B |
| March 19, 2024 | 91.45B |
| March 18, 2024 | 91.27B |
| Date | Value |
|---|---|
| March 15, 2024 | 91.80B |
| March 14, 2024 | 92.45B |
| March 13, 2024 | 94.60B |
| March 12, 2024 | 93.53B |
| March 11, 2024 | 93.83B |
| March 08, 2024 | 93.58B |
| March 07, 2024 | 91.76B |
| March 06, 2024 | 90.48B |
| March 05, 2024 | 90.93B |
| March 04, 2024 | 90.01B |
| March 01, 2024 | 90.08B |
| February 29, 2024 | 89.82B |
| February 28, 2024 | 90.57B |
| February 27, 2024 | 90.97B |
| February 26, 2024 | 90.88B |
| February 23, 2024 | 91.63B |
| February 22, 2024 | 90.67B |
| February 21, 2024 | 91.19B |
| February 20, 2024 | 89.75B |
| February 16, 2024 | 89.17B |
| February 15, 2024 | 91.42B |
| February 14, 2024 | 91.01B |
| February 13, 2024 | 91.62B |
| February 12, 2024 | 92.77B |
| February 09, 2024 | 91.80B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
71.01B
Minimum
Dec 30 2020
112.22B
Maximum
Dec 08 2022
88.08B
Average
85.56B
Median
Jul 19 2021
Market Cap Benchmarks
| Amgen Inc | 145.72B |
| Johnson & Johnson | 359.35B |
| Eli Lilly and Co | 695.32B |
| Pfizer Inc | 148.28B |
| CymaBay Therapeutics Inc (DELISTED) | -- |
Market Cap Related Metrics
| PE Ratio | 14.88 |
| PS Ratio | 3.106 |
| PEG Ratio | 0.639 |
| Price to Book Value | 3.653 |
| Price to Free Cash Flow | 11.35 |
| Price | 66.96 |
| Earnings Yield | 6.72% |
| PEGY Ratio | 0.5353 |
| Operating PE Ratio | 9.563 |
| Normalized PE Ratio | 12.75 |